home / stock / oprx / oprx news


OPRX News and Press, OptimizeRx Corporation From 05/09/19

Stock Information

Company Name: OptimizeRx Corporation
Stock Symbol: OPRX
Market: NASDAQ
Website: optimizerx.com

Menu

OPRX OPRX Quote OPRX Short OPRX News OPRX Articles OPRX Message Board
Get OPRX Alerts

News, Short Squeeze, Breakout and More Instantly...

OPRX - Technology - Top 5 Gainers / Losers

Gainers:  Control4 Corporation (NASDAQ: CTRL ) +40% . Pintec Technology Holdings (NASDAQ: PT ) +22% . TechTarget (NASDAQ: TTGT ) +21% . OptimizeRx Corporation (NASDAQ: OPRX ) +16% . Red Violet (NASDAQ: RDVT ) +12% . More news on: Control4 Corporation, Pintec Technology Holdings...

OPRX - CNDT, ROKU, STMP, and CTRL among midday movers

Gainers:  Control4 Corporation (NASDAQ: CTRL ) +39% . Roku (NASDAQ: ROKU ) +25% . TechTarget (NASDAQ: TTGT ) +20% . ShockWave Medical (NASDAQ: SWAV ) +19% . Dynavax Technologies (NASDAQ: DVAX ) +18% . Axonics Modulation Technologies (NASDAQ: AXNX ) +17% . Matrix Service Company ...

OPRX - OptimizeRx Reports First Quarter 2019 Results; Total Revenue Up 27% to $5.2 Million, Driving Non-GAAP Net Income up 130% to $833,000 or $0.06 per Diluted Share

ROCHESTER, Mich., May 08, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the first quarter ended March 31, 2019. Quarterly comparisons are to the same year-ago quarter. Q1...

OPRX - EVERSANA and OptimizeRx Partner to Deliver High Tech and High Touch Pharmaceutical Services

LAS VEGAS , April 30, 2019 /PRNewswire/ --  EVERSANA ™, the leading independent provider of global services to the life science industry, and   OptimizeRx Corp.  (NASDAQ: OPRX), a leading digital health messaging platform focused on affordability and adheren...

OPRX - OptimizeRx Strengthens Executive Leadership with Appointment of Chief Commercial Officer

ROCHESTER, Mich., April 29, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, has appointed Stephen Silvestro to the new position of chief commercial officer. Silvestro will be responsible for drivin...

OPRX - OptimizeRx Sets First Quarter 2019 Conference Call for Wednesday, May 8, 2019 at 4:30 p.m. ET

ROCHESTER, Mich., April 26, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, will hold a conference call on Wednesday, May 8, 2019 at 4:30 p.m. Eastern time to discuss results for the first quarter ...

OPRX - OptimizeRx to Present at Investor Conferences in May

ROCHESTER, Mich., April 23, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry, has been invited to present at three institutional investor conferences in May. Event: Oppenheimer Emerging Growth Conf...

OPRX - MicroCap Review Magazine Spring 2019 Issue Now Available

We are pleased to announce the release of the MicroCap Review Magazine Spring 2019 issue online and in print. Click here to read: MicroCap Review Spring 2019 The Spring 2019 issue of MicroCap Review, includes new content from our list of expert writers and opinion leaders, as well as...

OPRX - OptimizeRx Expands Investment in Hospitals and Health Systems with Latest Tech and Personnel Adds

ROCHESTER, Mich., April 08, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry, announced its latest platform integration with the health care industry’s leading acute electronic health record (EHR...

OPRX - A 68% Chance Of 100% Gain Was Present In Uplisted Stocks Over The Last 2 Years

I have been studying what effect uplisting has on the stock price of individual stocks. My first article concluded that a profit exceeding 25% was available in 65% of stocks that had uplisted during 2015 but that profit evaporated within the first year after uplisting. Only 10% of these same...

Previous 10 Next 10